Fresenius | FRE - Net Income


Fresenius reported EUR371M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Akzo Nobel EUR -178M 317M Sep/2026
Alcon AG USD 189M 28M Mar/2026
AstraZeneca USD 3.12B 610M Sep/2026
BASF EUR 155M 3.99B Sep/2026
Bayer EUR -672M 891M Sep/2026
Beiersdorf EUR 551M 164M Jun/2026
DaVita Healthcare Partners USD 265.4M 67.87M Jun/2026
Demant DKK 1.18B 758M Jun/2026
E.ON EUR 382M 1.85B Jun/2026
Essilor EUR 1.57B 638M Jun/2026
Fresenius EUR 371M 11M Sep/2026
Fresenius Medical Care EUR 160M 58.38M Sep/2026
Getinge SEK 839M 177M Jun/2026
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
GN Store Nord DKK -22M 933M Jun/2026
GRIFOLS EUR 162M 8M Sep/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 490M 169M Jun/2026
Novartis USD 1.2B 2.06B Sep/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
RWE EUR 1.54B 1.52B Jun/2026
Sanofi EUR 3.02B 2.68B Sep/2026
Smith & Nephew USD 303M 10M Jun/2026